261 related articles for article (PubMed ID: 14970777)
1. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy.
Gorsky M; Epstein JB; Parry J; Epstein MS; Le ND; Silverman S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):190-5. PubMed ID: 14970777
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the use of sialogogues in the clinical management of patients with xerostomia.
Chainani-Wu N; Gorsky M; Mayer P; Bostrom A; Epstein JB; Silverman S
Spec Care Dentist; 2006; 26(4):164-70. PubMed ID: 16927740
[TBL] [Abstract][Full Text] [Related]
3. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.
Frydrych AM; Davies GR; Slack-Smith LM; Heywood J
Aust Dent J; 2002 Sep; 47(3):249-53. PubMed ID: 12405466
[TBL] [Abstract][Full Text] [Related]
5. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study.
Epstein JB; Burchell JL; Emerton S; Le ND; Silverman S
Oral Surg Oral Med Oral Pathol; 1994 Jun; 77(6):610-4. PubMed ID: 7915026
[TBL] [Abstract][Full Text] [Related]
6. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
[TBL] [Abstract][Full Text] [Related]
7. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.
Jacobs CD; van der Pas M
Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429
[TBL] [Abstract][Full Text] [Related]
8. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
9. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis.
Moral Nakamura D; da Graça Pinto H; Baena Elchin C; Thomazotti Berard L; Abreu Alves F; Azeredo Alves Antunes L; Pena Coto N
Radiother Oncol; 2023 Sep; 186():109715. PubMed ID: 37207874
[TBL] [Abstract][Full Text] [Related]
11. Pilocarpine treatment in a mixed cohort of xerostomic patients.
Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C
Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.
Taweechaisupapong S; Pesee M; Aromdee C; Laopaiboon M; Khunkitti W
Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309
[TBL] [Abstract][Full Text] [Related]
13. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.
Fisher J; Scott C; Scarantino CW; Leveque FG; White RL; Rotman M; Hodson DI; Meredith RF; Foote R; Bachman DG; Lee N
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):832-6. PubMed ID: 12788192
[TBL] [Abstract][Full Text] [Related]
14. Pilocarpine for radiation-induced xerostomia in head and neck cancer.
Hawthorne M; Sullivan K
Int J Palliat Nurs; 2000 May; 6(5):228-32. PubMed ID: 12419994
[TBL] [Abstract][Full Text] [Related]
15. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
16. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia.
Taylor SE
Expert Opin Pharmacother; 2003 Sep; 4(9):1489-97. PubMed ID: 12943478
[TBL] [Abstract][Full Text] [Related]
18. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
19. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
LeVeque FG; Montgomery M; Potter D; Zimmer MB; Rieke JW; Steiger BW; Gallagher SC; Muscoplat CC
J Clin Oncol; 1993 Jun; 11(6):1124-31. PubMed ID: 8501499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
